• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指令需求:应对技术风险与科学不确定性。

Demand for command: responding to technological risks and scientific uncertainties.

作者信息

Stokes Elen

机构信息

Cardiff University, UK.

出版信息

Med Law Rev. 2013 Winter;21(1):11-38. doi: 10.1093/medlaw/fws042. Epub 2013 Jan 17.

DOI:10.1093/medlaw/fws042
PMID:23329016
Abstract

This article seeks to add to current theories of new governance by highlighting the predicament facing regulators and regulatees when dealing with new technologies. Using nanotechnologies as a study, it shows that new modes of governance (as opposed to traditional coercive, or command and control regulation) offer promising solutions to highly complex, uncertain, and contested problems of risk, such as those associated with new technologies. In this regard, nanotechnologies provide a useful test bed for the ambitions of newer, better modes of governance because there are not yet any fixed ideas about the appropriate course of action. The article suggests, however, that examples of new governance are less prominent than perhaps expected. Drawing on empirical data, it argues that, when faced with considerable epistemological, political, economic, and ethical uncertainties, regulatory stakeholders often exhibit a preference for more conventional command methods of regulation. That is not to say that new governance is entirely absent from regulatory policies on nanotechnologies, but that new governance is emerging in perhaps more subtle ways than the scholarly and policy literature predicted.

摘要

本文旨在通过强调监管者和被监管者在应对新技术时所面临的困境,为当前的新治理理论增添内容。以纳米技术作为研究对象,本文表明新的治理模式(与传统的强制性或命令与控制式监管相对)为高度复杂、不确定且存在争议的风险问题(如与新技术相关的问题)提供了有前景的解决方案。在这方面,纳米技术为更新、更好的治理模式的抱负提供了一个有用的试验场,因为对于适当的行动方针尚无任何固定的想法。然而,本文指出,新治理的例子并不像预期的那样突出。基于实证数据,本文认为,当面对相当多的认识论、政治、经济和伦理不确定性时,监管利益相关者通常表现出对更传统的命令式监管方法的偏好。这并不是说新治理在纳米技术监管政策中完全不存在,而是说新治理的出现方式可能比学术和政策文献所预测的更为微妙。

相似文献

1
Demand for command: responding to technological risks and scientific uncertainties.指令需求:应对技术风险与科学不确定性。
Med Law Rev. 2013 Winter;21(1):11-38. doi: 10.1093/medlaw/fws042. Epub 2013 Jan 17.
2
Science, ethics, and the "problems" of governing nanotechnologies.科学、伦理与纳米技术治理的“问题”。
J Law Med Ethics. 2009 Winter;37(4):749-58. doi: 10.1111/j.1748-720X.2009.00445.x.
3
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.问题陈述和方案评估(PFOA)将技术治理和环境风险评估联系起来:纳米技术和基因工程生物体问题分析的方法。
J Law Med Ethics. 2009 Winter;37(4):732-48. doi: 10.1111/j.1748-720X.2009.00444.x.
4
Foresight Study on the Risk Governance of New Technologies: The Case of Nanotechnology.新技术风险治理的前瞻性研究:以纳米技术为例
Risk Anal. 2016 May;36(5):1006-24. doi: 10.1111/risa.12470. Epub 2015 Sep 2.
5
Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.纳米技术和纳米材料的治理:原则、监管和重新协商社会契约。
J Law Med Ethics. 2009 Winter;37(4):706-23. doi: 10.1111/j.1748-720X.2009.00442.x.
6
Towards a more effective and efficient governance and regulation of nanomaterials.实现更有效和高效的纳米材料治理和监管。
Part Fibre Toxicol. 2017 Dec 19;14(1):54. doi: 10.1186/s12989-017-0235-z.
7
Considerations on the EU definition of a nanomaterial: science to support policy making.关于欧盟纳米材料定义的思考:为政策制定提供科学依据。
Regul Toxicol Pharmacol. 2013 Feb;65(1):119-25. doi: 10.1016/j.yrtph.2012.11.007. Epub 2012 Nov 29.
8
Implementing new modes of governance in the New Zealand health system: an empirical study.在新西兰卫生系统中实施新的治理模式:一项实证研究。
Health Policy. 2009 Dec;93(2-3):118-27. doi: 10.1016/j.healthpol.2009.06.004. Epub 2009 Jul 19.
9
The changing contours of experimental governance in European health care.欧洲医疗保健领域实验性治理的变化态势。
Soc Sci Med. 2014 May;108:89-96. doi: 10.1016/j.socscimed.2014.02.040. Epub 2014 Feb 26.
10
Steering vaccinomics innovations with anticipatory governance and participatory foresight.前瞻性治理和参与式预见引导疫苗学创新。
OMICS. 2011 Sep;15(9):637-46. doi: 10.1089/omi.2011.0087. Epub 2011 Aug 17.